ロード中...
Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients
To evaluate the pharmacokinetic effect of adding delavirdine mesylate to the antiretroviral regimens of human immunodeficiency virus (HIV)-infected patients stabilized on a full dosage of ritonavir (600 mg every 12 h), 12 HIV-1-infected subjects had delavirdine mesylate (400 mg every 8 h) added to t...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC153300/ https://ncbi.nlm.nih.gov/pubmed/12709342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.5.1694-1699.2003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|